Betaloan SUIK

Product NDC
80425-0347
11-digit product format
804250347
Labeler code
80425
Product ID
80425-0347_2a9c3847-6363-8f9e-e063-6394a90a15c9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Betamethasone Sodium Phosphate and Betamethasone Acetate
Dosage form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR
Labeler
Advanced Rx Pharmacy of Tennessee, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2023-07-26
Substance
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
Active strength
3; 3 mg/mL; mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Corticosteroid [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Betaloan SUIK
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BETAMETHASONE SODIUM PHOSPHATE3 mg/mL
BETAMETHASONE ACETATE3 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
7BK02SCL3WInternal UNII lookup
TI05AO53L7Internal UNII lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
016a47f2-8524-4178-e063-6294a90ab36eAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dde7b902-54a1-627e-12f1-9e6d244ab88cProduct name420250317
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
69b49899-11cf-4f7e-bd0a-7dc93b27311bProduct name320250130
bbdc14c7-d940-43b5-a2f7-36c425991f3cProduct name120240320
0a2fcc35-464b-9ec2-a622-753662cdd48cProduct name320240216
6f762601-17ef-4321-8f47-77783d3c4d8bProduct name320231116
1dbefad7-ab34-69c3-e51a-e7148aa38f70Product name520220921
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
7fea2046-07a9-4bb6-9409-828ac6f1f6dfProduct name120210201
f059f1a2-0e64-4839-9a7f-42687c91a44bProduct name120201007
4ea9e4b5-b452-48ad-9b25-b9a4d403405dProduct name120160310
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
4f07db9b-3707-3e2c-05b5-d7852ba808c4Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
80425-0347-1Betaloan SUIK5 mL in 1 VIAL, MULTI-DOSEINJECTION, SUSPENSION52
80425-0347-1Betaloan SUIK1 in 1 CARTONINJECTION, SUSPENSION12

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
80425-0347-1EA - Each80425-034776c77867-c45e-4710-83f2-4335e670591a12023-09-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
80425-0347BETALOAN SUIK (BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE) INJECTION, SUSPENSION [ADVANCED RX PHARMACY OF TENNESSEE, LLC]2Current NDC, 2 package rows20250102_016a47f2-8524-4178-e063-6294a90ab36e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Betaloan SUIKBETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATEAdvanced Rx Pharmacy of Tennessee, LLC016a47f2-8524-4178-e063-6294a90ab36e2024-12-31Warnings, Adverse reactionsExact identifier
ndc (product): 80425-0347

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
80425-0347-1804250347011 VIAL, MULTI-DOSE in 1 CARTON (80425-0347-1) / 5 mL in 1 VIAL, MULTI-DOSE2023-07-26NoNoCurrent